Physician profile
Beth A Piper
NPI 1740731876
$1,784.35
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $829 · 2021: $136 · 2022: $26.62.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $371.96 | 2019-2020 | |
| Novo Nordisk INC | $294.36 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $222.36 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $146.97 | 2019-2020 | |
| Lilly USA, LLC | $144.06 | 2019-2020 | |
| Radius Health, INC. | $140.10 | 2019 | |
| Insulet Corporation | $107.80 | 2019 | |
| Mannkind Corporation | $63.69 | 2019-2020 | |
| Abbvie INC. | $61.59 | 2019-2022 | |
| Medtronic Minimed, INC. | $48.76 | 2020 | |
| Ibsa Pharma INC. | $46.30 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.97 | 2019-2020 | |
| Eisai INC. | $24.94 | 2019 | |
| Lifescan, INC. | $17.36 | 2020 | |
| Pfizer INC. | $16.48 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.72 | 2020 | |
| Amarin Pharma, INC. | $13.42 | 2019 | |
| Grifols USA, LLC | $12.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Piper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.